Disagreement on outcome of SCOTUS Amgen v Sandoz ruling

13-06-2017

Disagreement on outcome of SCOTUS Amgen v Sandoz ruling

renaschild / iStockphoto.com

The US Supreme Court’s decision in the Amgen and Sandoz clash, which was handed down yesterday, has sparked disagreement between lawyers on the consequences of the ruling.


SCOTUS, patent, patent dance, BPCIA, FDA, IPR, biosimilar, Neupogen, Amgen, Sandoz

LSIPR